In the context of pediatrics, abacavir is significant because it is one of the few antiretroviral drugs approved for use in children. Pediatric HIV is a critical public health issue, and effective treatment options are essential for improving outcomes in affected children. Abacavir is often included in combination therapies due to its efficacy and safety profile.
